Puma Biotechnology Inc · NASDAQ:PBYI
Puma Biotechnology — Q2 2026 Earnings Presentation
8 slides from Puma Biotechnology's earnings presentation, Aug 6, 2026
Slide 1: Puma Biotechnology Earnings Call Commercial Update
Puma Biotechnology Earnings Call Commercial Update August 6, 2026
Slide 2: Forward-Looking Safe-Harbor Statement
Forward-Looking Safe-Harbor Statement This presentation contains forward-looking statements, including statements regarding commercialization of NERLYNX® and the potential indications and development of our drug candidates. All forward-looking statements involve risks and uncertainties that could ca
Slide 3: Puma's Pharmacy and Distributor Network
Puma’s Pharmacy and Distributor Network Hub Services Specialty Pharmacy Network (SP) Accredo CVS ONCO360 Patients Optum / Biologics Diplomat Specialty Distributor Network (SD) Sites of Care McKesson Academic Hospitals ASD / Oncology Supply Community Hospitals Cardinal Health Physician Practices DMS
Slide 4: $53.6 Million Net NERLYNX Revenue in Q2'26
$53.6 Million Net NERLYNX Revenue in Q2’26 ~9% increase in Q2’26 compared to Q2’25 ~28% increase in Q2’26 compared to Q1’26 Net Revenue (in $MM) Net Revenue (in $MM) 53.6 53.6 49.2 42.0 Q2'25 Q2'26 Q1'26 Q2'26 Inventory Change ($) Inventory Change ($) Q2’25 Q2’26 Q1’26 Q2’26 -$1.3 mil -$1 mil -$7.9
Slide 5: 2,929 Ex-Factory Bottles Were Sold in Q2'26
2,929 Ex-Factory Bottles Were Sold in Q2’26 ~12% increase in Q2’26 compared to Q2’25 ~26% increase in Q2’26 compared to Q1’26 Bottles Bottles 2,929 2,929 2,608 2,328 Q2'25 Q2'26 Q1'26 Q2'26 Copyright 2026 Puma Biotechnology 5
Slide 6: 2,986 bottles of U.S. Commercial Demand in Q2'26
2,986 bottles of U.S. Commercial Demand in Q2’26 ~11% increase in Q2’26 compared to Q2’25 ~8% increase in Q2’26 compared to Q1’26 Bottles Bottles 2,986 2,986 2,693 2,767 Q2'25 Q2'26 Q1'26 Q2'26 Copyright 2026 Puma Biotechnology 6
Slide 7: Rest of World Partnerships – Timelines
Rest of World Partnerships – Timelines Region Partner Regulatory Approvals Commercial Launches • 2019 – Ext. Adj. in Australia, Singapore • 2020 – Ext. Adj. in Brunei, Malaysia, New Zealand • 2020 – Singapore Australia / SE Asia • 2022 – Ext. Adj. in the Philippines; mBC in Singapore • 2021 – Malays
Slide 8: Puma Biotechnology Earnings Call Commercial Update
Puma Biotechnology Earnings Call Commercial Update August 6, 2026